CX Institutional’s Omnicell OMCL Stock Holding History

CX Institutional’s Portfolio OMCL Stock Details OMCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10	Closed	-$1K	–	935
2022 Q2	$1K	Buy	+10	New	+$1.15K	﹤0.01%	1153
2020 Q4	–	Sell	-270	Closed	-$20K	–	900
2020 Q3	$20K	Buy	+270	New	+$18.7K	﹤0.01%	546

Other funds holding OMCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

CX Institutional's OMCL Position: Q3 2022 in Review

CX Institutional sold out of Omnicell (OMCL) in Q3 2022, closing a stake of 10 shares — an estimated $1K sold.

CX Institutional first reported a position in OMCL in Q3 2020 and held it in 2 quarters. The position peaked at $20K in Q3 2020. 374 funds tracked by Wall St. Rank hold OMCL as of Q3 2022.

CX Institutional reported no remaining Omnicell position as of Q3 2022 after selling out during the quarter.
CX Institutional sold 10 Omnicell shares in Q3 2022, an estimated $1K.
CX Institutional first reported a position in Omnicell in Q3 2020 and held it in 2 quarters.
CX Institutional's Omnicell position peaked at $20K in Q3 2020.
374 funds tracked by Wall St. Rank held Omnicell as of Q3 2022.

Based on CX Institutional's 13F filing for Q3 2022, filed 4 Nov 2022.